Evidence map›Paper›PMID 32327568›Full record

ArticleScience (New York, N.Y.)2020

Structural basis of ER-associated protein degradation mediated by the Hrd1 ubiquitin ligase complex.

Xudong Wu, Marc Siggel, Sergey Ovchinnikov, Wei Mi, Vladimir Svetlov, Evgeny Nudler, Maofu Liao, Gerhard Hummer, Tom A Rapoport

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 147 papers.

0numbers the graph read from it
0cells of the map it votes in
147citing papers in PubMed
15.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

147 citing papers in PubMed, 237 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Structural evolution of the MTCH family of mitochondrial insertases.bioRxiv : the preprint server for biology · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

87 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Xudong WuHoward Hughes Medical Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-6492-2202
Marc SiggelDepartment of Theoretical Biophysics, Max Planck Institute of Biophysics, 60438 Frankfurt am Main, Germany.ORCID 0000-0003-3393-4988
Sergey OvchinnikovFaculty of Arts and Sciences, Center for Systems Biology, Harvard University, Cambridge, MA 02138, USA.ORCID 0000-0003-2774-2744
Wei MiDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-2845-4608
Vladimir SvetlovHoward Hughes Medical Institute and Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA.ORCID 0000-0002-1977-4271
Evgeny NudlerHoward Hughes Medical Institute and Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA.
Maofu LiaoDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-3481-450X
Gerhard HummerDepartment of Theoretical Biophysics, Max Planck Institute of Biophysics, 60438 Frankfurt am Main, Germany.ORCID 0000-0001-7768-746X
Tom A RapoportHoward Hughes Medical Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. tom_rapoport@hms.harvard.edu.ORCID 0000-0001-9911-4216
Howard Hughes Medical Institute · USHarvard University · USGoethe University Frankfurt · DEMax Planck Institute of Biophysics · DE

Funding

PROTEIN TRANSPORT INTO MAMMALIAN ENDOPLASMIC RETICULUMR01GM052586 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Tom A Rapoport · 1995 to 2026
$11.9M
Exploring the unknown protein universe using evolutionary informationDP5OD026389 · OD · HARVARD UNIVERSITY · PI OVCHINNIKOV, SERGEY L. · 2018 to 2022
$2.0M
Howard Hughes MedicalNIGMS NIH HHS R01 GM052586NIH HHS DP5 OD026389
6 · The paper itself

Abstract

Misfolded luminal endoplasmic reticulum (ER) proteins undergo ER-associated degradation (ERAD-L): They are retrotranslocated into the cytosol, polyubiquitinated, and degraded by the proteasome. ERAD-L is mediated by the Hrd1 complex (composed of Hrd1, Hrd3, Der1, Usa1, and Yos9), but the mechanism of retrotranslocation remains mysterious. Here, we report a structure of the active Hrd1 complex, as determined by cryo-electron microscopy analysis of two subcomplexes. Hrd3 and Yos9 jointly create a luminal binding site that recognizes glycosylated substrates. Hrd1 and the rhomboid-like Der1 protein form two "half-channels" with cytosolic and luminal cavities, respectively, and lateral gates facing one another in a thinned membrane region. These structures, along with crosslinking and molecular dynamics simulation results, suggest how a polypeptide loop of an ERAD-L substrate moves through the ER membrane.

Indexed as

Endoplasmic Reticulum-Associated DegradationProteolysisCarrier ProteinsCryoelectron MicroscopyEndoplasmic ReticulumMembrane GlycoproteinsMembrane ProteinsMolecular Dynamics SimulationMultiprotein ComplexesProtein DomainsProtein FoldingSaccharomyces cerevisiae ProteinsUbiquitin-Protein LigasesCarrier ProteinsDER1 protein, S cerevisiaeHRD1 protein, S cerevisiaeHRD3 protein, S cerevisiaeMembrane GlycoproteinsMembrane ProteinsMultiprotein ComplexesSaccharomyces cerevisiae ProteinsUbiquitin-Protein LigasesUsa1 protein, S cerevisiaeYos9 protein, S cerevisiae

Identifiers

PMID32327568
PMCPMC7380553
OpenAlexW3020597141

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.